{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Crohn%27s+Disease%2C+Active&page=2", "query": { "condition": "Crohn's Disease, Active", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Crohn%27s+Disease%2C+Active&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-07-23T23:11:39.905Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03105128", "title": "A Study of the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "placebo for risankizumab", "type": "DRUG" }, { "name": "risankizumab IV", "type": "DRUG" }, { "name": "risankizumab SC", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "16 Years to 80 Years" }, "enrollment_count": 931, "start_date": "2017-05-10", "completion_date": "2021-04-14", "has_results": true, "last_update_posted_date": "2022-07-06", "last_synced_at": "2026-07-23T23:11:39.905Z", "location_count": 117, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • Tempe, Arizona + 94 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03105128" }, { "nct_id": "NCT07184944", "title": "A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "Duvakitug", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "16 Years to 80 Years" }, "enrollment_count": 751, "start_date": "2026-01-22", "completion_date": "2034-03-20", "has_results": false, "last_update_posted_date": "2026-06-22", "last_synced_at": "2026-07-23T23:11:39.905Z", "location_count": 22, "location_summary": "Colorado Springs, Colorado • Kissimmee, Florida • Miami, Florida + 16 more", "locations": [ { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Kissimmee", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "New Albany", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT07184944" }, { "nct_id": "NCT00042055", "title": "CP-461 for the Treatment of Crohn's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "CP-461", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Astellas Pharma Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2002-07", "completion_date": "2003-09", "has_results": false, "last_update_posted_date": "2011-10-17", "last_synced_at": "2026-07-23T23:11:39.905Z", "location_count": 10, "location_summary": "Birmingham, Alabama • Orange, California • Gainesville, Florida + 7 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Orange", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00042055" }, { "nct_id": "NCT06257706", "title": "VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Moderately to Severely Active Crohn's Disease", "Crohn Disease", "Disease Crohn" ], "interventions": [ { "name": "Vedolizumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Alimentiv Inc.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 304, "start_date": "2024-08-07", "completion_date": "2029-02-06", "has_results": false, "last_update_posted_date": "2026-01-15", "last_synced_at": "2026-07-23T23:11:39.905Z", "location_count": 3, "location_summary": "Los Angeles, California • Charleston, South Carolina • Houston, Texas", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Charleston", "state": "South Carolina" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06257706" }, { "nct_id": "NCT03850509", "title": "Efficacy and Safety of Oral OPS-2071 in Participants With Crohn's Disease Showing Symptoms of Active Inflammation", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "OPS-2071", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 3, "start_date": "2020-02-25", "completion_date": "2020-05-22", "has_results": true, "last_update_posted_date": "2021-06-15", "last_synced_at": "2026-07-23T23:11:39.905Z", "location_count": 24, "location_summary": "Los Angeles, California • San Carlos, California • Colorado Springs, Colorado + 21 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Carlos", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Hialeah", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03850509" }, { "nct_id": "NCT03464136", "title": "Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Crohn Disease" ], "interventions": [ { "name": "Placebo for Ustekinumab", "type": "BIOLOGICAL" }, { "name": "Placebo for Adalimumab", "type": "BIOLOGICAL" }, { "name": "Ustekinumab (6 mg/kg)", "type": "BIOLOGICAL" }, { "name": "Ustekinumab (90 mg)", "type": "BIOLOGICAL" }, { "name": "Adalimumab (40 mg)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Janssen Scientific Affairs, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 386, "start_date": "2018-03-29", "completion_date": "2021-05-21", "has_results": true, "last_update_posted_date": "2025-04-29", "last_synced_at": "2026-07-23T23:11:39.905Z", "location_count": 67, "location_summary": "Mobile, Alabama • San Diego, California • Colorado Springs, Colorado + 60 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "San Diego", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Bridgeport", "state": "Connecticut" }, { "city": "Danbury", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03464136" }, { "nct_id": "NCT03759288", "title": "An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Crohn's Disease", "IBD" ], "interventions": [ { "name": "Brazikumab low dose", "type": "DRUG" }, { "name": "Brazikumab high dose", "type": "DRUG" }, { "name": "Humira®", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 89, "start_date": "2018-12-07", "completion_date": "2023-10-18", "has_results": true, "last_update_posted_date": "2026-06-23", "last_synced_at": "2026-07-23T23:11:39.905Z", "location_count": 38, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Lancaster, California + 31 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Lancaster", "state": "California" }, { "city": "Lincoln", "state": "California" }, { "city": "Poway", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03759288" }, { "nct_id": "NCT03241368", "title": "Clinical Study Comparing PillCam® Crohn's Capsule Endoscopy to Ileocolonoscopy (IC) Plus MRE for Detection of Active CD in the Small Bowel and Colon in Subjects With Known CD and Mucosal Disease.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Crohn Disease" ], "interventions": [ { "name": "Capsule Endoscopy", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Medtronic - MITG", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 187, "start_date": "2017-12-21", "completion_date": "2019-06-20", "has_results": true, "last_update_posted_date": "2020-06-09", "last_synced_at": "2026-07-23T23:11:39.905Z", "location_count": 24, "location_summary": "Mobile, Alabama • Scottsdale, Arizona • Jacksonville, Florida + 20 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Maywood", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03241368" }, { "nct_id": "NCT01345318", "title": "B0151005 Open-Label Extension Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "PF-04236921", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 191, "start_date": "2011-06", "completion_date": "2016-03", "has_results": true, "last_update_posted_date": "2024-01-12", "last_synced_at": "2026-07-23T23:11:39.905Z", "location_count": 62, "location_summary": "Scottsdale, Arizona • Tucson, Arizona • Lakewood, Colorado + 30 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Lakewood", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01345318" }, { "nct_id": "NCT04173273", "title": "A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "Etrasimod", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 379, "start_date": "2020-01-06", "completion_date": "2025-06-09", "has_results": true, "last_update_posted_date": "2026-07-01", "last_synced_at": "2026-07-23T23:11:39.905Z", "location_count": 192, "location_summary": "Dothan, Alabama • Mobile, Alabama • Peoria, Arizona + 62 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT04173273" } ] }